HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of protamine allergy with bivalirudin during coronary artery revascularization.

Abstract
A patient with impaired left ventricular function was scheduled for coronary artery bypass grafting. The patient's history revealed a life-threatening allergy to fish proteins. Therefore, because of the threat of cross-reactivity to protamine, a standard anticoagulation protocol with heparin/protamine was disapproved. Instead, complete coronary artery revascularization was successfully performed off-pump using bivalirudin as the anticoagulant.
AuthorsAndreas Koster, Ulrich Rosendahl, Eberhard von Hodenberg, Jürgen Ennker
JournalThe Annals of thoracic surgery (Ann Thorac Surg) Vol. 90 Issue 1 Pg. 276-7 (Jul 2010) ISSN: 1552-6259 [Electronic] Netherlands
PMID20609794 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Anticoagulants
  • Heparin Antagonists
  • Hirudins
  • Peptide Fragments
  • Protamines
  • Recombinant Proteins
  • bivalirudin
Topics
  • Anaphylaxis (chemically induced, prevention & control)
  • Anticoagulants (therapeutic use)
  • Coronary Artery Bypass, Off-Pump
  • Coronary Artery Disease (surgery)
  • Drug Hypersensitivity (prevention & control)
  • Heparin Antagonists (adverse effects)
  • Hirudins
  • Humans
  • Male
  • Middle Aged
  • Peptide Fragments (therapeutic use)
  • Protamines (adverse effects)
  • Recombinant Proteins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: